Crystallics is a science driven contract research organization specializing in identification and selection of the physical forms of drug substances, including salt, co-crystal, polymorph screening and form characterization and selection. Crystallics’ customer base is primarily in the pharmaceutical industry. Crystallics has developed a number of unique and proprietary technologies both in hardware and software, including High Throughput X-ray Powder Diffraction (HT-XRPD) technology and laboratory informatics, data analysis and predictive models. These unique, proprietary technologies, together with a strong customer focus, make Crystallics a supplier of choice in solid state research and pre-formulation. Over the last decade, the vast majority of large and medium size pharmaceutical companies, as well as, many smaller biotechnology companies have commissioned solid state and pre-formulation work with Crystallics. Crystallics’ value proposition is ‘successful drug development by intelligent solid form selection’. This value proposition is achieved through: